In the past week, EDSA stock has gone up by 85.34%, with a monthly gain of 127.74% and a quarterly surge of 55.40%. The volatility ratio for the week is 7.49%, and the volatility levels for the last 30 days are 10.40% for Edesa Biotech Inc The simple moving average for the last 20 days is 83.13% for EDSA stock, with a simple moving average of 1.11% for the last 200 days.
Is It Worth Investing in Edesa Biotech Inc (NASDAQ: EDSA) Right Now?
Moreover, the 36-month beta value for EDSA is 0.80. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for EDSA is 2.37M and currently, short sellers hold a 0.71% of that float. On February 13, 2025, EDSA’s average trading volume was 26.76K shares.
EDSA) stock’s latest price update
Edesa Biotech Inc (NASDAQ: EDSA) has seen a rise in its stock price by 94.67 in relation to its previous close of 1.86. However, the company has experienced a 85.34% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-02-13 that TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced that it has sold, in a private placement, an aggregate of 834 newly designated Series B-1 convertible preferred shares (“Series B-1 Preferred Shares”) and 3,468,746 common shares in a private placement priced at-the-market under the rules of the Nasdaq Stock Market. The purchase price per Preferred Share was $10,000 and the purchase price per common share was $1.92. Officers and directors of the Company purchased approximately $1.1 million of the securities sold in the offering.
EDSA Trading at 89.11% from the 50-Day Moving Average
After a stumble in the market that brought EDSA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.55% of loss for the given period.
Volatility was left at 10.40%, however, over the last 30 days, the volatility rate increased by 7.49%, as shares surge +99.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +42.99% upper at present.
During the last 5 trading sessions, EDSA rose by +78.63%, which changed the moving average for the period of 200-days by -21.04% in comparison to the 20-day moving average, which settled at $1.9707. In addition, Edesa Biotech Inc saw 115.52% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EDSA starting from Nijhawan Pardeep, who purchase 5,000 shares at the price of $4.00 back on Mar 25 ’24. After this action, Nijhawan Pardeep now owns 341,702 shares of Edesa Biotech Inc, valued at $20,000 using the latest closing price.
Stock Fundamentals for EDSA
The total capital return value is set at -3.54. Equity return is now at value -136.66, with -94.46 for asset returns.
Based on Edesa Biotech Inc (EDSA), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -246.92.
Currently, EBITDA for the company is -6.13 million with net debt to EBITDA at 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.91.
Conclusion
To wrap up, the performance of Edesa Biotech Inc (EDSA) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
